IP Library › Granted Patent US 12,006,291
Granted Patent B2
US 12,006,291 · App. 18/095,155 · Granted Jun 11, 2024

Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid

Inventors: Kaicheng Zhu (Belmont, MA); Tao Wang (Berkeley Heights, NJ); Jiajun Zhang (Cambridge, MA); Hui Cao (Belmont, MA); Ruichao Shen (Belmont, MA); Guoqiang Wang (Belmont, MA); George G. Wu (Waltham, MA); Yat Sun Or (Waltham, MA)
Assignee: Enanta Pharmaceuticals, Inc.
C07D209/42
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,006,291
App. No.
18/095,155
Granted
Jun 11, 2024
Kind
B2
Abstract

The present invention relates to processes for preparing a Compound (1): or a pharmaceutically acceptable salt or solvate thereof. Compound (1) is useful as in many pharmaceutical agents, especially is useful as key intermediate in the synthesis of certain SARS-CoV-2 3CLpro inhibitors.

Claims (50)

1. A process for producing Compound (1),

said process comprising the steps of:

(i) reacting Compound (a) with a bromination agent, to produce Compound (b):

(ii) reacting Compound (b) with N,O-dimethylhydroxylamine HCl, in the presence of an acid activation agent to produce Compound (c):

(iii) reducing Compound (c) with a reducing reagent to produce Compound (d):

(iv) reacting Compound (d) with Compound (d-1)

to produce Compound (e):

(v) reacting Compound (e) with a hydrogen source, to produce Compound (f):

and

(vi) hydrolyzing Compound (f) to produce Compound (1):

2. The process of claim 1 , wherein

in step (i), the bromination reagent is 1,3-dibromo-5,5-dimethylhydantoin;

in step (ii), the chlorination agent is oxalyl chloride;

in step (iii), the reducing reagent is diisobutylaluminium hydride;

in step (iv), the reaction is conducted in the presence of a catalyst selected from the group consisting of cuprous iodide, copper (I) oxide, and [1,1′-Bis(diphenylphosphino) ferrocene] palladium (II) dichloride, and an optional ligand;

in step (v), the reaction is conducted in the presence of a catalyst selected from the group consisting of palladium on carbon, palladium hydroxide on carbon, and Raney nickel; and

in step (vi), the reaction is conducted in the presence of a base to remove the Boc group and methyl ester.

3. The process of claim 1 , wherein

in step (i), the reaction is conducted in a solvent, wherein the solvent is sulfuric acid;

in step (ii), the reaction is conducted in the presence of dimethyl formamide as a catalyst;

in step (iii), the reaction is conducted at a temperature from about −70° C. to about −60° C.;

in step (iv), the catalyst is cuprous iodide, the ligand is 2,2′-bipyridine, and the base is potassium phosphate tribasic;

in step (v), the hydrogen source is H 2 , the catalyst is palladium on carbon (5-10 mol %), and the hydrogen pressure is about 1 atm; and

in step (vi), the reaction is conducted in the presence of sodium hydroxide and the resulting reaction mixture is treated with hydrogen chloride to form Compound (1).

4. A process for producing the Compound (1),

said process comprising the steps of:

(1) reacting Compound (a) with a bromination agent, to produce Compound (b):

(2) reacting Compound (b) with an acid activation reagent and a reducing agent to produce Compound (c-1):

(3) reacting Compound (c-1) with oxidizing agent to produce Compound (d):

(4) reacting Compound (d) with the compound of Formula (D-2)

to yield the compound of Formula (E):

wherein G 6 is -Cbz, -Fmoc, -Moz, or -Pnz;

(5) hydrolyzing the compound of Formula (E) to produce Compound (g):

and

(6) reacting Compound (g) with a hydrogen source in the presence of a hydrogenation catalyst, to produce Compound (1):

5. The process of claim 4 , wherein

in step (1), the bromination reagent is 1,3-dibromo-5,5-dimethylhydantoin;

in step (2), the acid activation agent is oxalyl chloride and the reducing agent is lithium borohydride;

in step (3), the oxidizing agent is trichloroisocyanuric acid with TEMPO;

in step (4), G 6 is -Cbz, and the reaction is conducted in the presence of cuprous iodide as a catalyst;

in step (5), the reaction is conducted in the presence of sodium hydroxide as a base; and

in step (6), the reaction is conducted in the presence of palladium on carbon as a catalyst.

6. The method of claim 2 , wherein in step (vi), the base is sodium hydroxide, potassium hydroxide, lithium hydroxide, or a mixture of two or more thereof.

7. The process of claim 2 , wherein

in step (i), the reaction is conducted in a solvent, wherein the solvent is sulfuric acid;

in step (ii), the reaction is conducted in the presence of dimethyl formamide as a catalyst;

in step (iii), the reaction is conducted at a temperature from about −70 ° C. to about −60 ° C.;

in step (iv), the catalyst is cuprous iodide, the ligand is 2,2′-bipyridine, and the base is potassium phosphate tribasic;

in step (v), the hydrogen source is H 2 , the catalyst is palladium on carbon (5-10 mol%), and the hydrogen pressure is about 1 atm; and

in step (vi), the reaction is conducted in the presence of sodium hydroxide and the resulting reaction mixture is treated with hydrogen chloride to form Compound (1).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2023
From: ZHU, KAICHENG; WANG, TAO; ZHANG, JIAJUN; CAO, HUI; SHEN, RUICHAO; WANG, GUOQIANG; WU, GEORGE G.; OR, YAT SUN
To: ENANTA PHARMACEUTICALS, INC.
Reel/Frame 064914/0993 →
Continuity (3)
Provisional Application 63307950 · Feb 8, 2022
Provisional Application 63298471 · Jan 11, 2022
Related Publication 20230234922A1 · Jul 27, 2023